Raymond James & Associates Tff Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$4.61 - $116.0 $15,674 - $394,400	3,400 Added 7.72%	47,450 $193,000
Q2 2022 Aug 12, 2022	BUY	$3.99 - $7.22 $34,713 - $62,814	8,700 Added 24.61%	44,050 $249,000
Q1 2022 May 11, 2022	SELL	$5.28 - $9.17 $7,920 - $13,755	-1,500 Reduced 4.07%	35,350 $223,000
Q4 2021 Feb 08, 2022	BUY	$6.86 - $9.65 $343 - $482	50 Added 0.14%	36,850 $327,000
Q3 2021 Nov 02, 2021	BUY	$7.21 - $10.49 $104,689 - $152,314	14,520 Added 65.17%	36,800 $284,000
Q2 2021 Aug 11, 2021	BUY	$8.48 - $13.61 $188,934 - $303,230	22,280 New	22,280 $214,000
Q3 2020 Nov 04, 2020	SELL	$5.86 - $18.47 $72,253 - $227,735	-12,330 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$3.79 - $6.08 $46,730 - $74,966	12,330 New	12,330 $71,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.